$SHC News

Insider Selling: Michael Petras Jr Unloads $21.17M Of Sotera Health Stock

Sotera Health (SHC) Q2 2026 Earnings Call Transcript

Insider Transaction: Michael Rutz Sells $2.83M Worth Of Sotera Health Shares

SHC Q2 Deep Dive: Broad-Based Growth, Leadership Transition, and Strategic Investments Shape Outlook

Sotera Health (SHC) Is Up 5.9% After Q2 Earnings Beat And Guidance Hike What’s Changed

Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25

Barclays Maintains Overweight on Sotera Health, Raises Price Target to $22

Piper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25

JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18

Sotera Health Q2 Earnings Call Highlights

Sotera Health Company Q2 2026 Earnings Call Summary

Sotera Health Company 2026 Q2 - Results - Earnings Call Presentation

Sotera Health (NASDAQ:SHC) Beats Q2 Estimates and Raises Guidance, But Shares Slip

Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates

Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript

Sotera Health Company (NASDAQ:SHC) Surprises With Strong Q2 CY2026

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Sotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M Estimate

Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B Est